Literature DB >> 8573078

Antigenicity and conformational analysis of the Zn(2+)-binding sites of two Zn(2+)-metalloproteases: Leishmania gp63 and mammalian endopeptidase-24.11.

K P Soteriadou1, A K Tzinia, E Panou-Pamonis, V Tsikaris, M Sakarellos-Daitsiotis, C Sakarellos, Y Papapoulou, R Matsas.   

Abstract

The antigenic properties of the Zn(2+)-binding region of two Zn(2+)-metalloproteases, Leishmania surface protease gp63 and mammalian endopeptidase-24.11 (E-24.11), possessing in their active site the characteristic amino acid sequence HEXXH, were investigated by using oligoclonal antibodies raised against two synthetic peptides, V1VTHEMAHALG11 (pepgp63) and V1IGHEITHGFD11 (pepE-24.11), containing the respective Zn(2+)-binding sites of the cognate protein. The affinity-purified antibodies, tested on synthetic peptides modelled from the active sites of ten different Zn(2+)-metalloproteases, showed high selectivity for their respective peptides. However, cross-reactivity was revealed when the antibodies were tested against the gp63 and E-24.11 molecules. A panel of synthetic peptide analogues and peptides of various size was synthesized and used for the fine antigenic characterization of pepgp63 and pepE-24.11. The shortest peptides capable of significant antibody binding were the pentapeptides V1VTHE5 and E5ITHG9 for pepgp63 and pepE-24.11 respectively. His4 and Glu5 were found to be indispensable for anti-pepgp63 binding to pepgp63, whereas in the case of pepE-24.11, Glu5 and His8 were found to be critical. The conformational characteristics of the two peptides correlate well with the observed differences in their antigenicity. 1H-NMR studies showed that pepgp63 adopts a folded structure whereas pepE-24.11 takes up a rather flexible conformation. Moreover, the antigenically critical His4 of pepgp63 contributes to the structural stabilization of the peptide. Similarly, the antigenically critical His8 of pepE-24.11 is involved in partial structural stabilization of its C-terminal region. The generated antibodies may be useful tools for identifying and classifying proteins possessing similar Zn(2+)-binding motifs and/or environments.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8573078      PMCID: PMC1216929          DOI: 10.1042/bj3130455

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  55 in total

1.  The promastigote surface protease of Leishmania.

Authors:  C Bordier
Journal:  Parasitol Today       Date:  1987-05

2.  High-affinity enkephalin-degrading peptidase in brain is increased after morphine.

Authors:  B Malfroy; J P Swerts; A Guyon; B P Roques; J C Schwartz
Journal:  Nature       Date:  1978-11-30       Impact factor: 49.962

Review 3.  Biochemistry of genetic recombination: energetics and mechanism of DNA strand exchange.

Authors:  S C Kowalczykowski
Journal:  Annu Rev Biophys Biophys Chem       Date:  1991

4.  Identification and isolation of the Leishmania transferrin receptor.

Authors:  C S Voyiatzaki; K P Soteriadou
Journal:  J Biol Chem       Date:  1992-05-05       Impact factor: 5.157

5.  A two-dimensional NMR study of the antimicrobial peptide magainin 2.

Authors:  D Marion; M Zasloff; A Bax
Journal:  FEBS Lett       Date:  1988-01-18       Impact factor: 4.124

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Downregulation of enkephalin-mediated inflammatory responses by CD10/neutral endopeptidase 24.11.

Authors:  M A Shipp; G B Stefano; L D'Adamio; S N Switzer; F D Howard; J Sinisterra; B Scharrer; E L Reinherz
Journal:  Nature       Date:  1990-09-27       Impact factor: 49.962

8.  A 94-kDa protein, identified as neutral endopeptidase-24.11, can inactivate atrial natriuretic peptide in the vascular endothelium.

Authors:  J M Soleilhac; E Lucas; A Beaumont; S Turcaud; J B Michel; D Ficheux; M C Fournié-Zaluski; B P Roques
Journal:  Mol Pharmacol       Date:  1992-04       Impact factor: 4.436

9.  Identification of monomeric and oligomeric forms of a major Leishmania infantum antigen by using monoclonal antibodies.

Authors:  K P Soteriadou; A K Tzinia; M G Hadziantoniou; S J Tzartos
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

10.  Jurkat T cells express a functional neutral endopeptidase activity (CALLA) involved in T cell activation.

Authors:  B Mari; F Checler; G Ponzio; J F Peyron; S Manie; D Farahifar; B Rossi; P Auberger
Journal:  EMBO J       Date:  1992-11       Impact factor: 11.598

View more
  5 in total

1.  A computational study on cannabinoid receptors and potent bioactive cannabinoid ligands: homology modeling, docking, de novo drug design and molecular dynamics analysis.

Authors:  Serdar Durdagi; Manthos G Papadopoulos; Panagiotis G Zoumpoulakis; Catherine Koukoulitsa; Thomas Mavromoustakos
Journal:  Mol Divers       Date:  2009-06-18       Impact factor: 2.943

2.  Expression of a novel Leishmania gene encoding a histone H1-like protein in Leishmania major modulates parasite infectivity in vitro.

Authors:  Fotini T Papageorgiou; Ketty P Soteriadou
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

3.  Surface Zn-proteinase as a molecule for defense of Leishmania mexicana amazonensis promastigotes against cytolysis inside macrophage phagolysosomes.

Authors:  M B Seay; P L Heard; G Chaudhuri
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

4.  Conformational analysis of the ΜΒΡ83-99 (Phe91) and ΜΒΡ83-99 (Tyr91) peptide analogues and study of their interactions with the HLA-DR2 and human TCR receptors by using molecular dynamics.

Authors:  C Potamitis; M-T Matsoukas; T Tselios; T Mavromoustakos; S Golič Grdadolnik
Journal:  J Comput Aided Mol Des       Date:  2011-09-06       Impact factor: 3.686

5.  In situ immunolocalization and stage-dependent expression of a secretory serine protease in Leishmania donovani and its role as a vaccine candidate.

Authors:  Rajdeep Choudhury; Partha Das; Siddhartha Kumar Bhaumik; Tripti De; Tapati Chakraborti
Journal:  Clin Vaccine Immunol       Date:  2010-01-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.